In carrying out these functions, a mutation in exon 41, which encodes the kinase domain of LRRK2, is thought to enhance the kinase activity of LRRK2, leading to neurological disorders such as PD [4,5]. The gene discussed is LRRK2; the disease is Parkinson disease.